Search
The Newsletter
The Principals
Reports
Conferences
Physician Surveys
Consulting
Contact Us
Home


Pricing and Ordering Information


                                          Surgeons' Adoption of Endovascular Techniques

  • What do over 200 endovascular surgeons think is the MOST important issue that needs 
    to be resolved before carotid stenting and embolic protection will be widely endorsed?  

  • What do they think is the treatment of choice for routine carotid stenosis?  

Find out the answers to these and other important questions from Medtech Insight's 
Pr3 Physician Survey
conducted at the 2002 International Congress XV on 
Endovascular Interventions
 

Research Methods
Over 275 physicians participated in the survey, which was conducted using audience 
response technology over a three-day period.  Physicians were asked 38 questions 
regarding various subjects including abdominal aortic aneurysm (AAA) repair, carotid 
stenting, and catheter-based peripheral vascular techniques
.

                            SURVEY QUESTIONS
                                      (n=sample size)

1.       Are you a practicing:

1.      Vascular Surgeon

2.      CT or CV Surgeon

3.      Other Surgeon

4.      Interventional Cardiologist

5.      Interventional Radiologists

6.      All others

            n=222

 

 

2.      Where are you from?

1.      U.S.

2.      Canada

3.      Mexico

4.      Europe

5.      Asia

6.      South America/Central America

7.      Africa

8.      Australia

9.      Other

            n=228

 

 

3.      If you are from the U.S., in what region of the country do you practice?

1.      Northeast

2.      South

3.      Southwest (including Texas)

4.      Midwest

5.      West

            n=155

 

 

4.      Who is performing endovascular therapy at your hospital?

1.      Radiologist

2.      Cardiologist

3.      Vascular Surgeon

4.      Thoracic Surgeon

5.      1 & 2

6.      1 & 3

7.      1, 2 & 3

8.      All of the above

            n=210

 

 

5.      From what specialty do you receive the most patient referrals for endovascular
    treatment?

1.      Primary Care

2.      Radiologist

3.      Cardiologist

4.      Surgeon

5.      Other

            n=217

 

 

6.      How many patients do you see per week, who are candidates for endovascular therapy?

1.      1-2

2.      3-5

3.      6-7

4.      8-10

5.      >10

            n=202

 

 

7.      How many endovascular procedures do you perform per month?

1.      1-2

2.      3-5

3.      6-7

4.      8-10

5.      >10

            n=203

 

 

8.      What percent of the procedures that you perform today are done by endovascular
    techniques?

1.      <5%

2.      6%-15%

3.      16%-25%

4.      26%-50%

5.      51%-75%

6.      >75%

            n=200

 

 

9.      In 5 years, what percent of the procedures you perform will be by endovascular
    techniques?

1.      <5%

2.      6 %-15%

3.      16%-25%

4.      26%-50%

5.      51%-75%

6.      >75%

            n=194

 

 

10.  How would you prefer to get trained in new endovascular techniques?

1.      Company sponsored training course

2.      CME course

3.      Course at a major meeting

4.      Residency/fellowship training

5.      From your peers

6.      Other

            n=212

 

 

11.  Graft related endoleak (Type I/Type III) is a significant risk factor for aneurysm rupture
  and/or indications for secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=218

 

 

12.  Sidebranch endoleak (Type II) is a significant risk factor for aneurysm rupture and/or
  indications for secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=260

 

 

13.  Stent-graft migration is a significant risk factor for aneurysm rupture and/or indications for
  secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=271

 

 

14.  Stent-graft distortion is a significant risk factor for aneurysm rupture and/or indications for
  secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=257

 

 

15.  Aneurysm expansion is a significant risk factor for aneurysm rupture and/or indications for
  secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=275

 

 

16.  Aneurysm stability (failure to shrink) is a significant risk factor for aneurysm rupture and/or
  indications for secondary intervention:

1.      Always

2.      Often

3.      Sometimes

4.      Rarely

5.      Never

            n=276

 

 

17.  When do you treat Type II endoleak?

1.      If Type II endoleak persists at 1 month

2.      If Type II endoleak persists at 6 months

3.      If Type II endoleak persists at 12 months

4.      ONLY if the AAA expands

5.      Never

            n=244

 

 

18.  What is your preferred method to treat Type II endoleak?

1.      Conservative

2.      Percutaneous coil embolization

3.      Translumbar puncture

4.      Laparoscopic ligation

5.      Open surgery

            n=236

 

 

19.  For those who do perform endo repair of AAA, how many have you performed?

1.      <20

2.      21-50

3.      51-100

4.      >100

            n=159

 

 

20.  For those who do perform endo repair of TAA, how many have you performed?

1.      <10

2.      10-20

3.      21-50

4.      >50

            n=121

 

 

21.  Have you had personal experience with a fatal or near-fatal iliac artery rupture during
  stent-grafting?

1.      Yes

2.      No

            n=154

 

 

22.  What do you think is the main determinant in endograft procedure failure?

1.      Aneurysm size

2.      Graft attachment system

3.      Graft fabric

4.      Patient selection

5.      Physician technical error

            n=210

 

 

23.  Upon approval by the FDA, the immediate percentage conversion from bare metal stents to
  drug eluting stents will be:

1.      >75%

2.      50-75%

3.      25-49%

4.      <25%

            n=158

 

 

24.  Conceptually, which AAA stent-design appeals to you MOST?

1.      Unibody design, unsupported

2.      Unibody design, supported

3.      Modular design, unsupported

4.      Modular design, supported

5.      Other

            n=81

 

 

25.  In what percentage of cases do you use femoral arteriotomy closure devices post-routine
  cardiac catheterization?

1.      <25%

2.      25-50%

3.      51-75%

4.      >75%

            n=132

 

 

26.  Persisting immediate endoleak with risk of AAA rupture is best predicted by:

1.      Increase in maximal diameter of AAA sac on CT

2.      With/Without contrast

3.      Increase in AAA sac volume

4.      Failure of AAA sac to shrink in

5.      Volume/Diameter

6.      Persistent high pressure in "endotension" catheter

            n=131

 

 

27.  Ruptured AAA endograft results must have the same durability as elective endograft:

1.      Agree

2.      Disagree

            n=187

 

 

28.  What do you think is the treatment of choice for a routine carotid stenosis?

1.      Surgery

2.      Carotid Stenting

            n=169

 

 

Note:  The following question was asked before and after a debate.  Results from each sample size are provided.

29.  Do you currently use, or plan to use embolic protection devices in your practice?

1.      Yes

2.      No

            n=148

            n=133 

 

 

30.  Should carotid stenting be reserved for the more experienced centers only?

1.      Yes

2.      No

            n=142

 

 

31.  On principle, which kind of protection would you favor?

1.      Balloon occlusion

2.      Filter

3.      Reversed flow

            n=144

 

 

32.  Are there any risks connected to the utilization of a cerebral protection device?

1.      No

2.      Yes, minimal

3.      Yes, relevant